Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 5/20 | 0.84 |
| ▸ | MAPT | P10636 | 5/20 | 0.84 |
| ▸ | MEN1 | O00255 | 4/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.80 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | GLS | O94925 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9385833 | 0.92 | KMT2A (0.76) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL9382874 | 0.87 | POLB (0.77) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL9381707 | 0.86 | MAPT (0.67) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL23027786 | 0.85 | POLB (0.63) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL23027815 | 0.85 | MAPT (0.65) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL23027798 | 0.84 | LMNA (0.78) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL23027890 | 0.83 | ALDH1A1 (0.60) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL17261495 | 0.82 | PKM (0.72) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL29451720 | 0.81 | PKM (0.70) | POLBMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL4604023 | 0.81 | PKM (0.70) | POLBMAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220202783-A1 | Use Of ADAM9 Inhibitor As Immunomodulator | CHINA MEDICAL UNIVERSITY (TW) | 2022-06-30 | — | — | US | disclosed |
| US-11357759-B2 | Composition including ADAM9 inhibitor and the use thereof | CHINA MEDICAL UNIVERSITY (TW) | 2022-06-14 | — | — | US | disclosed |
| US-20210052562-A1 | Composition Including ADAM9 Inhibitor And The Use Thereof | CHINA MEDICAL UNIVERSITY (TW) | 2021-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11357759-B2 | Composition including ADAM9 inhibitor and the use thereof | ADAM9, ADAM8, ADAM17 | POLB 2797/4885MAPT 1737/4885MEN1 385/4885 |
| US-20220202783-A1 | Use Of ADAM9 Inhibitor As Immunomodulator | ADAM9, ADAM17, ADAM10 | POLB 4111/4885MAPT 3674/4885MEN1 1247/4885 |
| US-20210052562-A1 | Composition Including ADAM9 Inhibitor And The Use Thereof | ADAM9, ADAM8, ADAM17 | POLB 2797/4885MAPT 1737/4885MEN1 385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.